ADAdriana V. Diaz

Adriana V. Diaz

*This is an algorithmically generated author record based on publicly available information.

Adriana V. Diaz has a total of 37 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Correction: ‘Variable efficacy of praziquantel among Schistosoma -infected ruminants of northern Senegal—a drug trial and population genetic study across two contrasting epidemiological regions’ (2026), by Diaz et al .

    by Adriana V. Diaz, Nicolas D. Diouf, Elsa Léger, Kelsilandia Aguiar-Martins, Anna Borlase, Cheikh Binetou-Fall, Clement Cahen, Mariama Sène, Martin Walker, Joanne P. Webster

  • Open Access

    Variable efficacy of praziquantel among Schistosoma -infected ruminants of northern Senegal—a drug trial and population genetic study across two contrasting epidemiological regions

    by Adriana V. Díaz, Diouf Nicolas D, Elsa Léger, Kelsilandia Aguiar-Martins, Anna Borlase, Cheikh Binetou-Fall, Clement Cahen, Mariama Sène, Martin Walker, Joanne P. Webster

    While efforts to eliminate schistosomiasis as a public health problem gather momentum, the potential zoonotic risk posed by livestock Schistosoma species via viable hybridization in sub-Saharan Africa has only begun to be appreciated. Recent research revealed widescale use and misuse of praziquantel (PZQ) in livestock among subsistence farmers within West Africa, in response to the often high morbidities and mortalities, and hence socioeconomic impact, of animal schistosomiasis. Such findings raised policy discussion into the potential need to formalize livestock schistosomiasis treatments, balanced against the necessity to protect against PZQ resistance. Here, we present results of an anthelmintic efficacy trial in which 25 mg kg−1 of veterinary-formula PZQ was given orally to naturally Schistosoma spp.-infected domestic ruminants of northern Senegal. Miracidial reduction rates revealed acceptable efficacy levels within cattle infected with S. bovis, but near zero efficacies in goats and sheep infected with S. curassoni and/or hybrids. Furthermore, increased miracidial output post-PZQ was observed among several individuals, particularly within sheep. There was a significant increase in body condition in both cattle and sheep post-PZQ. Microsatellite molecular markers of parasites from bovines indicated a greater level of population genetic differentiation between pre- and post-PZQ samples than between villages, with a genetic signature of inbreeding in one village with the lowest PZQ efficacy. We discuss our findings in terms of their implications and applications towards reaching the WHO elimination targets and the need for future One Health research. This article is part of the Science+ meeting issue ‘Parasite evolution and impact in action: exploring the importance and control of hybrid schistosomes’.


  • Open Access

    Mimicking superinfection exclusion disrupts alphavirus infection and transmission in the yellow fever mosquitoAedes aegypti

    by Christine M. Reitmayer, Emily Levitt, Sanjay Basu, Barry Atkinson, Rennos Fragkoudis, Andres Merits, Sarah Lumley, Will Larner, Adriana V. Diaz, Sara Rooney, et al.

    Multiple viruses, including pathogenic viruses, bacteriophages, and even plant viruses, cause a phenomenon termed superinfection exclusion whereby a currently infected cell is resistant to secondary infection by the same or a closely related virus. In alphaviruses, this process is thought to be mediated, at least in part, by the viral protease (nsP2) which is responsible for processing the nonstructural polyproteins (P123 and P1234) into individual proteins (nsP1–nsP4), forming the viral replication complex. Taking a synthetic biology approach, we mimicked this naturally occurring phenomenon by generating a superinfection exclusion-like state inAedes aegyptimosquitoes, rendering them refractory to alphavirus infection. By artificially expressing Sindbis virus (SINV) and chikungunya virus (CHIKV) nsP2 in mosquito cells and transgenic mosquitoes, we demonstrated a reduction in both SINV and CHIKV viral replication rates in cells following viral infection as well as reduced infection prevalence, viral titers, and transmission potential in mosquitoes.


  • Top Cited Papers
    Open Access

    Reaching the World Health Organization elimination targets for schistosomiasis: the importance of a One Health perspective

    by Adriana V. Díaz, Martin Walker, Joanne P. Webster

    The past three years has seen the launch of a new World Health Organization (WHO) neglected tropical diseases (NTDs) roadmap, together with revised control and elimination guidelines. Across all, there is now a clear emphasis on the need to incorporate a One Health approach, recognizing the critical links between human and animal health and the environment. Schistosomiasis, caused by Schistosoma spp. trematodes, is a NTD of global medical and veterinary importance, with over 220 million people and untold millions of livestock currently infected. Its burden remains extremely high in certain regions, particularly within sub-Saharan Africa, despite over two decades of mass preventive chemotherapy (mass drug administration), predominantly to school-aged children. In Africa, in contrast to Asia, any zoonotic component of schistosomiasis transmission and its implications for disease control has, until recently, been largely ignored. Here, we review recent epidemiological, clinical, molecular, and modelling work across both Asia and Africa. We outline the evolutionary history and transmission dynamics of Schistosoma species, and emphasize the emerging risk raised by both wildlife reservoirs and viable hybridization between human and animal schistosomes. To achieve the 2030 WHO roadmap elimination targets, a truly multi-disciplinary One Health perspective must be implemented. This article is part of the theme issue ‘Challenges and opportunities in the fight against neglected tropical diseases: a decade from the London Declaration on NTDs’.


  • Open Access

    Modelling livestock test-and-treat: A novel One Health strategy to control schistosomiasis and mitigate drug resistance

    by Adriana V. Díaz, Sebastien Lambert, M. Inês Neves, Anna Borlase, Elsa Léger, Nicolas D. Diouf, Mariama Sène, Joanne P. Webster, Martin Walker

    Schistosomiasis, a neglected tropical disease, is a widespread chronic helminthiasis reported in 78 countries, predominantly those within sub-Saharan Africa, as well as Latin America, Asia, and most recently, even Europe. Species of the causative blood fluke infect not only humans but also animals, and hybrids between previously assumed human-specific and animal-specific schistosomes are being increasingly reported. Existing control programs across Africa focus on humans and rely heavily on mass drug administration of praziquantel, the sole drug available against schistosomiasis. Praziquantel is safe and highly efficacious but could become ineffective if resistance emerges. To reach the revised World Health Organization goal of elimination of schistosomiasis as a public health problem, and interruption of transmission within selected regions, by 2030, new consideration of the role of animal reservoirs in human transmission in general, and whether to also treat livestock with praziquantel in particular, has been raised. However, whilst there are no dedicated control programs targeting animals outside of Asia, there are emerging reports of the use and misuse of praziquantel in livestock across Africa. Therefore, to effectively treat livestock in Africa and to help mitigate against the potential evolution of praziquantel resistance, structured control strategies are required. Here, using a transmission modelling approach, we evaluate the potential effectiveness of a theoretical test-and-treat (TnT) strategy to control bovine schistosomiasis using a currently available point-of-care diagnostic test (developed for human use) to detect circulating cathodic antigen (POC-CCA). We show that implementing TnT at herd-level from 2022 to 2030 could be highly effective in suppressing infection in cattle and even, in lower prevalence settings, reaching nominal ‘elimination’ targets. We highlight the importance of enhancing the specificity of POC-CCA for use in livestock to avoid unnecessary treatments and discuss the outstanding challenges associated with implementing TnT as part of a holistic One Health approach to tackling human and animal schistosomiasis.


  • Open Access

    Surveillance and control of SARS‐CoV‐2 in mustelids: An evolutionary perspective

    by Adriana V. Díaz, Martin Walker, Joanne P. Webster

    The relevance of mustelids in SARS-CoV-2 transmission has become increasingly evident. Alongside experimental demonstration of airborne transmission among ferrets, the major animal model for human respiratory diseases, transmission of SARS-CoV-2 within and/or between commercial mink farms has occurred and continues to occur. The number of mink reared for the luxury fur trade is approximately 60.5 million, across 36 mustelid-farming countries. By July 2021, SARS-CoV-2 outbreaks have been reported in 12 of these countries, at 412 European and 20 North American mink farms. Reverse zoonotic transmission events (from humans to mink) have introduced the virus to farms with subsequent extensive mink-to-mink transmission as well as further zoonotic (mink-to-human) transmission events generating cases amongst both farm workers and the broader community. Overcrowded housing conditions inherent within intensive mink farms, often combined with poor sanitation and welfare, both guarantees spread of SARS-CoV-2 and facilitates opportunities for viral variants, thereby effectively representing biotic hubs for viral transmission and evolution of virulence. Adequate preventative, surveillance and control measures within the mink industry are imperative both for the control of the current global pandemic and to mitigate against future outbreaks.


  • Open Access

    Exposure to environmental stressors result in increased viral load and further reduction of production parameters in pigs experimentally infected with PCV2b

    by Robert Patterson, Amanda Nevel, Adriana V. Diaz, Henny M. Martineau, Theo Demmers, Christopher Browne, Bettina Mavrommatis, Dirk Werling